In tumor cells, LRP1, as the endocytic receptor of MMP2 and MMP9, can make malignant cells in an adherent state by activating ERK and inhibiting the JNK signaling pathway, which is conducive to invasion 49,50,51. This evidence concerns the gene MMP9 and neoplasm.